INTRODUCTION
============

Thrombotic microangiopathies (TMA) are a heterogeneous group of potentially fatal diseases[@B1] ^-^ [@B4]. The most severe short-term TMA is thrombotic thrombocytopenic purpura (TTP)[@B2]. The pathophysiology of this disease is due to the formation of microthrombi in the endothelium due to platelet hyperaggregation to the non-cleaved von Willebrand factor (VWF) 1 multimers. ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) is the protein responsible for the cleavage of vWF multimers. Its deficiency may be congenital (cTTP) or acquired, usually of autoimmune origin[@B1] ^-^ [@B4].

Acquired TTP is usually mediated by anti-ADAMTS13 antibodies or immune mediated Thrombotic Thrombocytopenic Purpura (iTTP). It presents as microangiopathic hemolytic anemia, thrombocytopenia and neurological alterations[@B2]. The presentation is acute in most cases and invariably fatal, if not treated adequately[@B3].

Infections are important causes of immune responses in the context of iTTP[@B5]. Reports of TTP secondary to parvovirus B19, dengue, HIV and viral hepatitis demonstrate the potential of viral infections to act as a triggering factor of microangiopathic diathesis[@B6] ^-^ [@B9]. The present case report describes iTTP secondary to dengue and chikungunya virus coinfection in the current epidemic of arbovirus infections in a State in Northeastern Brazil.

CASE REPORT
===========

A 28-year-old male patient with a previous history of immune thrombocytopenic purpura (ITP), diagnosed six years ago but had stopped had treatment approximately five years ago, was hospitalized with clinical and epidemiological diagnosis of arbovirus infection (fever, asthenia, myalgia and arthralgia). On admission, thrombocytopenia (12,000/mm^3^) and anemia (8.0 g/dL) were observed ([Table 1](#t1){ref-type="table"}). Oral corticosteroid therapy was started with prednisone 1 mg/kg/day. On the third day of hospitalization, he had headache with vomiting, associated with mental confusion and, subsequently, motor aphasia and right hemiplegia. Considering the sudden worsening of the patient\'s overall conditions, he was referred to the intensive care unit. Nuclear magnetic resonance imaging of the brain was performed to rule out acute ischemic or hemorrhagic events. The neuroimaging examination showed no alterations. Faced with an acute neurological worsening, the possibility of TTP was considered. Analysis of the peripheral smear showed innumerable schizocytes, confirming the presence of TMA. Plasmapheresis and pulse therapy with methylprednisolone were started due to the hypothesis of TTP.

###### Temporal evolution of Hb (g / dL), platelets (/ mm^3^) and LDH (U / L). On the 5^th^ day, the plasma exchange started

                              D0        D3       D6       D7       D8        D9        D10       D11       D12       D13       D17
  --------------------------- --------- -------- -------- -------- --------- --------- --------- --------- --------- --------- -------------
  Hb (g/dL)                   8.0       6.4      6.3      7.4      7.3       7.8       9.5       9.9       10.6      11.6      **10.3**
  Platelets (/mm^3^)          12.000    11.000   34.000   54.000   105.000   156.000   202.000   239.000   301.000   398.000   **366.000**
  LDH (U/L)                   1.166     1.461                      660       445       775       481       364       444       **339**
  Reticulocyte (relative %)   **1,9**   **6**                                                                                  

\* Reference value: Hb = 13,5-18,0 g/dL; Platelets = 140.000- 450.000; LDH = 200 −480 U/L; Reticulocyte count relative (%) = 0,5 - 2,3

Serological results were IgM positive for chikungunya and dengue viruses, and initially, the presence of IgG only raised to chikungunya virus (Euroimmun Medizinische Labordiagnostika, Lübeck, Germany). Serological tests for hepatitis virus B and C were negative, as well as for retroviruses (only HIV). Regarding retroviruses, other representatives are not routinely investigated and, in this case, they were not suspected. The patient also had negative results for antinuclear antibody (ANA) ([Table 2](#t2){ref-type="table"}). During the follow-up, serological results for dengue and chikungunya were confirmed, at this time showing the presence of IgG antibodies to chikungunya as well as to dengue virus. The serological test for zika virus was not performed following guidelines from Brazilian Ministry of Health, which recommend not to test zika virus when serological tests for dengue and chikungunya are positive.

###### Serologic assessment showing the presence of IgM/IgG anti CHIKV and IgM antiDen. ADAMTS13 low activity and the presence of an inhibitor confirms the diagnosis of TTP

  -----------------------------------------------------------------
  Serologic assessment   D3                     D17
  ---------------------- ---------------------- -------------------
  Dengue IgM/IgG         reactive/nonreactive   reactive/reactive

  Chikungunya IgM/IgG    reactive/reactive      reactive/reactive

  ANA                    nonreactive            

  Anti HIV1-2            nonreactive            

  VDRL                   nonreactive            

  antiHBS                nonreactive            

  antiHCV                nonreactive            

  HbsAg                  nonreactive            

  Activity ADAMTS13/\    4%/ reactive           
  ADAMTS13 inhibitor                            
  -----------------------------------------------------------------

There was a decrease in lactate dehydrogenase (LDH) ([Table 1](#t1){ref-type="table"}). Plasmapheresis was maintained until platelet counts remained higher than 150,000 for three consecutive days ([Figure 1](#f1){ref-type="fig"}). Complete remission of neurological signs occurred after the first plasmapheresis.

![Platelets (/mm^3^) from the day of arrival until discharge. The patient underwent plasmapheresis from day 2 to day 5](1678-9946-rimtsp-60-S1678-9946201860048-gf01){#f1}

DISCUSSION
==========

There have been rare descriptions in the literature of TTP association with chikungunya fever, or coinfection with other arboviruses, such as dengue virus[@B6] ^-^ [@B9]. The aim of this publication is to provide data for further studies and alert health teams to identify arboviruses-related emergency associations.

This case report describes a severe hematological complication associated with emerging arboviruses, such as chikungunya virus, which is endemic in Brazil in a coinfection with dengue virus. The patient was admitted with unspecific symptoms, including fever, myalgia and arthralgia, which is common to the three currently endemic arboviruses in Brazil. As the symptomatology is not specific of any of the three arboviruses, they may vary from patient to patient, in most cases only serological tests can differentiate one infection from another, according to the current literature[@B10].

The formation of anti-ADAMTS13 antibodies has been implicated in the genesis of many cases of acquired TTP[@B4]. In this context, infections are important triggers for microangiopathic diathesis[@B5]. The patient had TMA-compatible clinical manifestations. The presence of acute neurological alterations is compatible with TTP. In addition, serological results together with clinical manifestations and the occurrence of arboviruses epidemic in Northeastern Brazil confirm the diagnosis of dengue and chikungunya virus coinfection in this case.

Chikungunya fever is a disease spread by mosquitos of the *Aedes aegypti* genus. It belongs to the genus alphavirus, has RNA as its genetic material and enters host cells through the envelope of glycoproteins, especially E1 and E2. The first cases were described in 1952-1953 in Africa[@B5]. The disease symptomatology is most often joint-related, with a recent description of potentially severe neurological and immunological phenomena such as encephalitis[@B5], Guillain-Barré syndrome[@B5] ^,^ [@B11] and immune-mediated thrombocytopenia[@B11]. The arrival of the virus in Brazil was probably due to the 2014 World Cup, when zika and chikungunya viruses became part of the arboviruses circulating in the country[@B5].

Dengue fever is an endemic disease in Northeast Brazil, with episodes of cyclic epidemics, especially during the rainy season at the beginning of each year. It is also transmitted by mosquitos[@B11]. It belongs to the genus flavivirus and has RNA as its genetic material. The infection is most often asymptomatic, with some patients developing arthralgia, thrombocytopenia and episodes of vascular extravasation, which, if not adequately managed, can progress to severe forms. Dengue may be associated with neurological and hematological complications[@B12], among others.

The two arboviruses infections may present with myalgia, headache, arthralgia and thrombocytopenia. Anemia is not a common finding for these diseases[@B12] ^,^ [@B13]. Coinfection can occur, especially because the two viruses share the same vector, the *Aedes aegypti* mosquito. TTP cases were reported in association with dengue fever[@B6] ^,^ [@B7] and Congo-Crimean hemorrhagic fever with chikungunya infection[@B8].

Severe deficiency of the ADAMTS 13 protein (defined as activity below 10%) plays an important role in the genesis of TTP. This proteinase cleaves the vWF multimer, which participates in the coagulation and platelet aggregation pathways[@B1].

In this case, the patient was at first clinically and epidemiologically diagnosed with an arbovirus infection due to the dengue and chikungunya fever epidemic in Northeastern Brazil. Subsequently, worsening of anemia, thrombocytopenia, neurological alterations and the presence of schizocytes in the peripheral blood smear suggested the diagnosis of TMA[@B7] ^,^ [@B8]. The ADAMTS 13 activity below 10% and positive serological tests (IgM and IgG) to dengue and chikungunya confirmed the arboviruses coinfection associated with iTTP secondary to the arboviruses infections.

CONCLUSION
==========

Although there is a lot of information on hematological complications of dengue virus infections, there same is not true regarding chikungunya virus infections. In this context, due to the severity and lethality of TTP, it is important that health professionals are prepared to identify similar cases and that adequate therapy is instituted in a timely manner. More studies are required to evaluate the impact of dengue and chikungunya virus infection on the genesis of TMA, especially TTP.
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